46. Malignant rheumatoid arthritis Clinical trials / Disease details

Clinical trials : 4,356 / Drugs : 2,567 - (DrugBank : 415) / Drug target genes : 192 - Drug target pathways : 228

3 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	ChiCTR2100053221	2022-02-01	2021-11-16	Effectiveness evaluation of the combined application of motor imagery and tai chi to alleviate the fear of falling in RA patients	Effectiveness evaluation of the combined application of motor imagery and tai chi to alleviate the fear of falling in RA patient	Rheumatoid Arthritis (RA)	group A:Routine nursing mode;group B:Motor imagery therapy;group C:Tai Chi balance three;group D:Movement imagination therapy + Tai Chi balance;	The Second Xiangya Hospital of Central South University	NULL	Recruiting	18		Both	group A:21;group B:21;group C:21;group D:21;		China
2	NCT02892370 (ClinicalTrials.gov)	August 2016	2/9/2016	Effect of a High-fat Meal on the Pharmacokinetics of SHR0302 and Mass Balance Study in Healthy Subjects	An Open Label, Randomized, Two-period, Crossover Study to Assess the Effect of Food on SHR0302 and Mass Balance in Healthy Volunteers	Rheumatoid Arthritis	Drug: SHR0302	Jiangsu HengRui Medicine Co., Ltd.	NULL	Recruiting	18 Years	45 Years	Male	14	Phase 1	China
3	NCT00711074 (ClinicalTrials.gov)	June 2008	3/7/2008	Mass Balance and Metabolic Profiling of [14C]AZD5672 in Healthy Male Volunteers	An Open-Label, Phase I Study to Assess the Excretion of Radioactivity, Metabolic Profiles and Pharmacokinetics Following a Single Oral Dose of [14C]AZD5672 in Healthy Male Volunteers	Rheumatoid Arthritis	Drug: AZD5672	AstraZeneca	NULL	Completed	50 Years	N/A	Male	4	Phase 1	United Kingdom